FDA Notices of Judgment Collection, 1908-1966
3622. Misbranding of Dexedrine Sulfate tablets, Gantrisin tablets, and Seconal Sodium capsules. U. S. v. Gary Drug Co., Inc., Jacob H. Raverby, and Tobias Levine. Pleas of guilty. Fine of $200 against corporation and 50 against each individual.
Drugs and Devices, 1940-1963 Evidence Numbers:
F. D. C. No. 31244. Sample Nos. 79828-K, 79832-K, 79982-K, 79983-K, 79985-K to 79987-K, incl. , 79991-K to 79995-K, incl.
May 1952 Seizure Dates:
September 7, 8, 13, 14, 19, and 28; October 2, 6, and 10, 1950
Dexedrine Sulfate tablets, Gantrisin tablets, and Seconal Sodium capsules
Gary Drug Co., Inc., Boston, Mass., Jacob H. Raverby, president and treasurer of the corporation, and Tobias Levine, a pharmacist employed by the corporation. Court Jurisdiction:
District of Massachusetts Seizure Location:
Pennsylvania, New Jersey, and Indiana
The National Library of Medicine believes this item to be in the public domain